Currently there are no randomised trials to guide the management of Takotsubo syndrome (TTS). The Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology includes proposed diagnostic and management algorithms. Given the absence of randomised trial evidence, these algorithms do not replace clinical judgement (Lyon et al 2016).
Click on the image to enlarge
ACE, angiotensin-converting-enzyme; ARB, angiotensin-receptor blocker; AV-block, atrioventricular block; HF, heart failure; IABP, intra-aortic balloon pump; IV, intravenous; LV, left ventricle; LVAD, left ventricular assist device; LVD, left ventricular dysfunction; LVEF, left ventricular ejection fraction; LVOTO, left ventricular outflow tract obstruction; NOAC, novel oral anticoagulant; QTc, QT-time corrected for heart rate; RV, right ventricle; TTS, takotsubo syndrome; VA-ECMO, venoarterial extracorporeal membrane oxygenation; VF, ventricular fibrillation; VT, ventricular tachycardia.
© 2018 Ghadri et al. European Heart Journal
1Lyon, A.R., Bossone, E., Schneider, B., Sechtem, U., Citro, R., Underwood, S.R., Sheppard, M.N., Figtree, G.A., Parodi, G., Akashi, Y.J. and Ruschitzka, F., 2016. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 18(1), pp.8-27.
2Ghadri, J.R., Wittstein, I.S., Prasad, A., Sharkey, S., Dote, K., Akashi, Y.J., Cammann, V.L., Crea, F., Galiuto, L., Desmet, W. and Yoshida, T., 2018. International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. European heart journal, 39(22), pp.2047-2062.
Stay up-to-date
Development of this website was supported by a grant from the Rosemary Bryant AO Research Centre, University of South Australia
Copyright © 2019 Takotsubo